IMPURITIES AVAILABLE FOR 'Omarigliptin'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Omarigliptin. Omarigliptin is a long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus to improve glycemic control. It works by inhibiting the DPP-4 enzyme, which prolongs the activity of incretin hormones (GLP-1 and GIP) that stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner. Unlike other DPP-4 inhibitors, omarigliptin has a long half-life, allowing once-weekly oral administration. It is metabolically stable, primarily excreted unchanged in urine, and suitable for patients with mild to moderate renal impairment. The drug is weight-neutral and has a low risk of hypoglycemia when used alone. Common side effects include nasopharyngitis, headache, and mild gastrointestinal discomfort. Omarigliptin is often used as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas. Buy high quality Omarigliptin from Omsynth Lifesciences.